Eyedaptic recently announced results from an independent real-world clinical evaluation demonstrating substantial immediate improvements in functional vision among patients with advanced retinal disease. The findings were presented by David Almeida, MD, MBA, PhD, FRCSC, at the American Retina Forum Annual Meeting, which took place Aug. 5-8 in South Lake Tahoe, California. Let’s start with Eyedaptic. Specializing in vision-enhancement technology, the privately-held company’s products are designed with wearable vision aid software enabled by AI and augmented reality (AR) hardware. Unlike therapies created to slow disease progression, Eyedaptic’s technology is intended to enhance functional vision by digitally optimizing visual information in real time, helping patients utilize their remaining peripheral vision more effectively. Explain how this is done. Through the proprietary Simulated Natural Vision Software, which works by optimizing a patient’s functional (remaining) peripheral vision via pixel manipulation—“simulating” clearer vision. - The intent: To give patients an improved quality of life with a hands-free, easy-to-wear glasses design (take a look at the clinical research supporting the tech). Which patients is this technology designed for? The company is currently targeting patients diagnosed with age-related macular degeneration (AMD) and diabetic retinopathy (DR). And that software is included in these smart glasses? Indeed. In fact, it’s included in Eyedaptic's entire line of AI-enhanced eyewear: the EYE5, EYE6—and as of March 2026—the EYE7. Among the features of these glasses: - Lightweight design (weighing in at less than 3 oz) - Facial detection capabilities - Auto-zoom mode for viewing text in various situations - Contrast enhancement controls (for additional image enhancements) - 2-in-1 wearable and hand-held magnifier - EyeSwitch technology As a side note: Prior iterations of the company’s products also encompassing this patented technology include the EYE2, EYE3, and EYE4. Are they cleared by the FDA? According to Eyedaptic, its smart glasses are Class I exempt medical